Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand
about
Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitorSimilar Biological Activities of Two Isostructural Ruthenium and Osmium ComplexesExtremely Tight Binding of a Ruthenium Complex to Glycogen Synthase Kinase 3The Crystal Structure of BRAF in Complex with an Organoruthenium Inhibitor Reveals a Mechanism for Inhibition of an Active Form of BRAF KinaseAn Organometallic Inhibitor for the Human Repair Enzyme 7,8-Dihydro-8-oxoguanosine TriphosphataseBioactive cyclometalated phthalimides: design, synthesis and kinase inhibitionNon-ATP-Mimetic Organometallic Protein Kinase InhibitorOrganotrifluoroborates and monocoordinated palladium complexes as catalysts--a perfect combination for Suzuki-Miyaura coupling.Development of organometallic S6K1 inhibitors.Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.Scope of the Suzuki-Miyaura cross-coupling reactions of potassium heteroaryltrifluoroborates.From imide to lactam metallo-pyridocarbazoles: distinct scaffolds for the design of selective protein kinase inhibitors.Automated Multistep Continuous Flow Synthesis of 2-(1H-Indol-3-yl)thiazole Derivatives.Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Toward the development of a potent and selective organoruthenium mammalian sterile 20 kinase inhibitor.Organoruthenium antagonists of human A₃ adenosine receptors.Assessing protein-ligand docking for the binding of organometallic compounds to proteins.
P2860
Q21142745-3AC35D4E-F653-4A2C-A8AC-CB7254C8E250Q27650404-395772C1-FDBF-40EB-BB34-0626B43DFEE0Q27652994-CFDCA048-27EA-4FF3-928A-3EEDD7AAC3B6Q27654846-59338072-AB0E-4747-BBAC-446AF485FC97Q27680660-62C35BBF-DD49-405E-98BC-309314182C40Q27681382-AB84ADE8-5A67-41C8-AC8D-B2208B8CA5D9Q27681838-CCF910DF-9769-42E2-BAA8-582D73460C75Q34051116-93AFA3BB-776B-48F5-B18F-7CAE2441C598Q34891733-D2E02E07-9740-4CB9-96AE-A88DE4F1788CQ35207714-85DEEBF4-06E6-4AC3-9750-A14EF952B112Q36341898-B7A71BCE-B272-4A6B-A3A8-668A59F25139Q37146977-225260A6-5863-4388-85E4-528C971AF323Q37457019-50D26CB4-2717-4124-A6E8-5D4DDA1B9E9EQ37636142-5C35BEC0-527D-4E7A-B4D0-2D6A0A2296C9Q38052406-15D9853A-9178-4206-BA7F-E57D9639B5A1Q43097841-D69ED47B-3D79-4834-B1A8-C06DE689ADAFQ51047023-20DCEFF8-E797-4CD6-8FA2-449EC5F9C521Q51127935-07BCAFC7-71E1-4E9D-A257-5672AC7B6706
P2860
Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@ast
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@en
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@nl
type
label
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@ast
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@en
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@nl
prefLabel
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@ast
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@en
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@nl
P2093
P356
P1476
Ruthenium half-sandwich comple ...... carbazole pharmacophore ligand
@en
P2093
Douglas S Williams
Howard Bregman
Jasna Maksimoska
Nicholas Pagano
Richard D Webster
P304
P356
10.1039/B700433H
P407
P50
P577
2007-04-21T00:00:00Z